Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands		3 Months Ended		9 Months Ended
		Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenues:
Total revenues		$ 0	$ 200	$ 5,442	$ 1,466
Operating expenses:
Research and development		1,909	2,605	7,462	10,507
General and administrative		2,077	2,046	9,432	5,480
Total operating expenses		3,986	4,651	16,894	15,987
Loss from operations		(3,986)	(4,451)	(11,452)	(14,521)
Other (expense) income:
Interest expense (with related parties $0 for the three and nine months ended September 30, 2023 and $465 and $1,366 for the three and nine months ended September 30, 2022, respectively)		(21)	(559)	(65)	(1,699)
Change in fair value of rights from Private Placement		(1,401)	0	(180)	0
Change in fair value measurement of notes payable		(4)	(418)	(17)	(542)
(Loss) gain on extinguishments of debt, net		0	(236)	0	259
Other (expense) income, net		101	(3)	298	(17)
Total other (expense) income, net		(1,325)	(1,216)	36	(1,999)
Net income (loss)		(5,311)	(5,667)	(11,416)	(16,520)
Net (loss) income attributable to noncontrolling interest		69	(82)	29	(81)
Net income (loss) attributable to Kineta, Inc.		$ (5,380)	$ (5,585)	$ (11,445)	$ (16,439)
Net loss per share, basic		$ (0.46)	$ (1.14)	$ (1.09)	$ (3.42)
Net loss per share, diluted		$ (0.46)	$ (1.14)	$ (1.09)	$ (3.42)
Weighted-average shares outstanding, basic	[1]	11,738	4,891	10,505	4,808
Weighted-average shares outstanding, diluted	[1]	11,738	4,891	10,505	4,808
Collaboration revenue [Member]
Revenues:
Total revenues		$ 0	$ 0	$ 442	$ 0
Licensing revenues [Member]
Revenues:
Total revenues		0	0	5,000	965
Grant revenues [Member]
Revenues:
Total revenues		$ 0	$ 200	$ 0	$ 501

[1] Included in the denominator were 577,000 and 530,000 weighted-average shares of common stock warrants for the three and nine months ended September 30, 2023, respectively, with an exercise price of $0.14. Included in the denominator were 155,000 and 153,000 weighted-average shares of common stock warrants for the three and nine months ended September 30, 2022, respectively, with an exercise price of $0.14.